Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists

Details for Australian Patent Application No. 2008236639 (hide)

Owner Merck & Co., Inc.

Inventors Bao, Jianming; Jiang, Jinlong; Devita, Robert J.; Mills, Sander G.; Kassick, Andrew J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008236639

PCT Pub. Number WO2008/124143

Priority 60/922,663 10.04.07 US

Filing date 7 April 2008

Wipo publication date 16 October 2008

International Classifications

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/124143 Priority application(s): WO2008/124143

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008236644-Sulfur compounds as inhiibitors of hepatitis C virus NS3 serine protease

2008236638-Patient-specific stem cell lines derived from human parthenogenetic blastocysts